Inalco Biochemicals

Inalco is a global biotechnology company specializing in the production of high-purity carbohydrates and active pharmaceutical ingredients (APIs). The company is recognized as a leading manufacturer of Lactulose, a key treatment for chronic constipation and hepatic encephalopathy. Beyond its pharmaceutical offerings, Inalco provides a wide range of specialized biochemicals for research and diagnostics, including IPTG and X-Gal. With a strong focus on complex carbohydrate synthesis, the company operates GMP-compliant manufacturing facilities to serve the global healthcare and life sciences markets. In 2021, Inalco was acquired by Sacco System, integrating its expertise into a broader portfolio of functional ingredients and biotechnological solutions.